

| 货号 | HX959266 |
|---|---|
| 品牌 | abinScience |
| 描述 |
Cizutamig (HX959266) is a research-grade recombinant antibody targeting CD269. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| 种属反应性 | Human |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 同种型 | Fab-IgG |
| 克隆号 | Cizutamig |
| 表达系统 | Mammalian cells |
| 靶标 | Tumor necrosis factor receptor superfamily member 17, B-cell maturation protein, CD269, TNFRSF17, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E |
| 内毒素水平 | < 10 EU/mg |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| Accession号 | Q02223 & P07766 |
| 状态 | Liquid |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 别名 | Emb 06, Emb06, CN-106, CND-106, CND106 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control | Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507) |

SDS-PAGE for Anti-Human BCMA & CD3 epsilon Bispecific Reference Antibody (Cizutamig, RUO)







24小时产品查询

扫一扫关注我们

专属渠道经理